Angelini Ventures' follow-on investment powers CoMind's $60 Million funding round for breakthrough brain monitoring technology 10/20/2025 Category: INVESTMENTS
Angelini Ventures Co-Leads €105 Million Series A for Adcytherix to advance Next-Generation ADC Therapies 10/16/2025 Category: INVESTMENTS
Angelini Ventures leads €12M Follow-On Investment in Serenis, European digital health leader 10/1/2025 Category: PORTFOLIO NEWS
Portfolio company Therini Bio achieves major milestone with first patient dosed in Alzheimer's Phase 1b trial 7/29/2025 Category: PORTFOLIO NEWS
NUCLIDIUM raises €84 Million Series B to advance copper-based radiopharmaceutical platform for precision oncology 7/10/2025 Category: INVESTMENTS
Angelini Ventures invests in Elkedonia's breakthrough depression treatment 6/11/2025 Category: INVESTMENTS
Angelini Ventures